Nicola Berretta

Dr. Nicola Berretta

Fondazione Santa Lucia, Rome, Lazio, Italy
orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 1993 in Nature
Verified
Journal Article
Closed access
PDF file
ZBZafar I. Bashir
Zafar I. Bashir
ZBZuner A. Bortolotto
Zuner A. Bortolotto
CDCeri H. Davies
Ceri H. Davies
NBNicola Berretta
Nicola Berretta
AIAndrew J. Irving
Andrew J. Irving
GCGraham L. Collingridge
Graham L. Collingridge

3 April 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
ANAnnalisa Nobili
Annalisa Nobili
ELEmanuele Claudio Latagliata
Emanuele Claudio Latagliata
Maria ViscomiMaria Viscomi
Maria Viscomi
VCVirve Cavallucci
Virve Cavallucci
DCDebora Cutuli
Debora Cutuli
MDMarcello D’amelio
Marcello D’amelio
Alterations of the dopaminergic (DAergic) system are frequently reported in Alzheimer’s disease (AD) patients and are commonly linked to cognitive and non-cognitive symptoms. However, the cause of DAergic system dysfunction in AD remains to be elucidated. We investigated alterations of the midbrain DAergic system in the Tg2576 mouse model of AD, overexpressing a mutated human amyloid precursor protein (APPswe). Here, we found an age-dependent DAergic neuron loss in the ventral tegmental area (VTA) at pre-plaque stages, although substantia nigra pars compacta (SNpc) DAergic neurons were intact. The selective VTA DAergic neuron degeneration results in lower DA outflow in the hippocampus and nucleus accumbens (NAc) shell. The progression of DAergic cell death correlates with impairments in CA1 synaptic plasticity, memory performance and food reward processing. We conclude that in this mouse model of AD, degeneration of VTA DAergic neurons at pre-plaque stages contributes to memory deficits and dysfunction of reward processing.

1 October 1996 in Neuroscience
Verified
Journal Article
Closed access
NBNicola Berretta
Nicola Berretta
RJR.S.G Jones
R.S.G Jones

15 April 2003 in Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
SMSilvia Marinelli
Silvia Marinelli
Vincenzo Di MarzoVincenzo Di Marzo
Vincenzo Di Marzo
NBNicola Berretta
Nicola Berretta
IMIsabel Matias
Isabel Matias
MMMauro Maccarrone
Mauro Maccarrone
Nicola Biagio MercuriNicola Biagio Mercuri
Nicola Biagio Mercuri
Growing evidence regarding the function of vanilloid receptor-1 (VR1) in the brain suggests potential central roles of this receptor, previously described to occur primarily in peripheral sensory neurons. In the present study, we used electrophysiological and biochemical techniques to investigate the function and the endogenous stimulation of VR1 in dopaminergic neurons of the substantia nigra pars compacta (SNc). The VR1 agonist capsaicin increased the frequency of both TTX-sensitive and -insensitive spontaneous EPSCs (sEPSCs) without affecting their amplitude, suggesting a presynaptic site of action. In contrast, no effect was detected with regard to GABAergic transmission. No increase in sEPSC frequency was observed in the presence of cadmium chloride, while the voltage-dependent calcium channel antagonist ω-conotoxin MVIIC did not prevent capsaicin action. The VR1 antagonists capsazepine and iodoresiniferatoxin (IRTX) blocked the effects of capsaicin. Importantly, IRTX per se reduced sEPSC frequency, suggesting a tonic activity of VR1. The endogenous VR1 agonist anandamide (AEA) produced an IRTX-sensitive increase in the frequency of sEPSCs on dopaminergic neurons that was more pronounced when protein kinase A had been activated. Furthermore, mass spectrometric analyses and binding experiments revealed high levels of endogenous AEA and specific binding of AEA to VR1 receptors in the SNc. These data suggest a tonic facilitation of glutamate release exerted by VR1 in the SNc through a stimulation of VR1 by endovanilloids, including anandamide. The increase in sEPSC frequency by VR1 onto midbrain dopaminergic neurons suggests the involvement of these receptors in motor and cognitive functions involving the dopaminergic system.

1 March 2000 in European Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
PCPaolo Calabresi
Paolo Calabresi
MNMaddalena Napolitano
Maddalena Napolitano
Diego CentonzeDiego Centonze
Diego Centonze
GMGirolama A. Marfia
Girolama A. Marfia
PGPaolo Gubellini
Paolo Gubellini
AGAlberto Gulino
Alberto Gulino

23 January 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RNRobert Nistico
Robert Nistico
DMDalila Mango
Dalila Mango
Georgia MandolesiGeorgia Mandolesi
Georgia Mandolesi
SPSonia Piccinin
Sonia Piccinin
NBNicola Berretta
Nicola Berretta
Diego CentonzeDiego Centonze
Diego Centonze
Abnormal use-dependent synaptic plasticity is universally accepted as the main physiological correlate of memory deficits in neurodegenerative disorders. It is unclear whether synaptic plasticity deficits take place during neuroinflammatory diseases, such as multiple sclerosis (MS) and its mouse model, experimental autoimmune encephalomyelitis (EAE). In EAE mice, we found significant alterations of synaptic plasticity rules in the hippocampus. When compared to control mice, in fact, hippocampal long-term potentiation (LTP) induction was favored over long-term depression (LTD) in EAE, as shown by a significant rightward shift in the frequency–synaptic response function. Notably, LTP induction was also enhanced in hippocampal slices from control mice following interleukin-1β (IL-1β) perfusion, and both EAE and IL-1β inhibited GABAergic spontaneous inhibitory postsynaptic currents (sIPSC) without affecting glutamatergic transmission and AMPA/NMDA ratio. EAE was also associated with selective loss of GABAergic interneurons and with reduced gamma-frequency oscillations in the CA1 region of the hippocampus. Finally, we provided evidence that microglial activation in the EAE hippocampus was associated with IL-1β expression, and hippocampal slices from control mice incubated with activated microglia displayed alterations of GABAergic transmission similar to those seen in EAE brains, through a mechanism dependent on enhanced IL-1β signaling. These data may yield novel insights into the basis of cognitive deficits in EAE and possibly of MS.